dpp 4 inhibitors and glp 1 agonists together GLP-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Dipeptidyl Peptidase-4 Inhibitors: A Systematic
Description
10.1002/pds.668 77 WhartonS.DaviesM.DickerD.LingvayI.MosenzonO.RubinoD
Finally, similar to GLP-1 RAs, the medication should not be used in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [31, 43]
These are not variations of the same drug class
There is, however, a class of medications known as GLP-1 agonists, which a medical professional may consider in the treatment of diagnosable diseases such as Type 2 diabetes
Drugs 70 (4), 489512
Can microdosing GLP-1s help with reducing side effects
